SG11201400325WA - Treating cough and tussive attacks - Google Patents
Treating cough and tussive attacksInfo
- Publication number
- SG11201400325WA SG11201400325WA SG11201400325WA SG11201400325WA SG11201400325WA SG 11201400325W A SG11201400325W A SG 11201400325WA SG 11201400325W A SG11201400325W A SG 11201400325WA SG 11201400325W A SG11201400325W A SG 11201400325WA SG 11201400325W A SG11201400325W A SG 11201400325WA
- Authority
- SG
- Singapore
- Prior art keywords
- treating cough
- tussive attacks
- tussive
- attacks
- cough
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161531432P | 2011-09-06 | 2011-09-06 | |
| PCT/GB2012/052190 WO2013034909A1 (en) | 2011-09-06 | 2012-09-06 | Treating cough and tussive attacks |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201400325WA true SG11201400325WA (en) | 2014-03-28 |
Family
ID=46845779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400325WA SG11201400325WA (en) | 2011-09-06 | 2012-09-06 | Treating cough and tussive attacks |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20140242174A1 (en) |
| EP (1) | EP2753323A1 (en) |
| JP (1) | JP2014525471A (en) |
| KR (1) | KR20140069091A (en) |
| CN (1) | CN103974699A (en) |
| AU (1) | AU2012306076A1 (en) |
| CA (1) | CA2847817A1 (en) |
| EA (1) | EA201490538A1 (en) |
| GB (3) | GB201304501D0 (en) |
| IL (1) | IL231301A0 (en) |
| MX (1) | MX2014002675A (en) |
| SG (1) | SG11201400325WA (en) |
| WO (2) | WO2013034910A1 (en) |
| ZA (1) | ZA201401658B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| JP2016518388A (en) | 2013-04-30 | 2016-06-23 | オティトピック インク． | Dry powder formulation and usage |
| CN106456595A (en) | 2014-02-10 | 2017-02-22 | 帕塔拉制药有限责任公司 | Mast cell stabilizers treatment for systemic disorders |
| DK3104854T3 (en) | 2014-02-10 | 2020-05-04 | Respivant Sciences Gmbh | MAST-CELL STABILIZERS FOR HEALTH DISEASE TREATMENT |
| WO2015127315A1 (en) * | 2014-02-20 | 2015-08-27 | Otitopic Inc. | Dry powder formulations for inhalation |
| KR20190075168A (en) * | 2014-04-08 | 2019-06-28 | 필립모리스 프로덕츠 에스.에이. | Nicotine formulations and methods of making the same |
| EP3331522A1 (en) | 2015-08-07 | 2018-06-13 | Patara Pharma LLC | Methods for the treatment of mast cell related disorders with mast cell stabilizers |
| US10265296B2 (en) | 2015-08-07 | 2019-04-23 | Respivant Sciences Gmbh | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders |
| US20170071248A1 (en) | 2015-09-16 | 2017-03-16 | Sansa Corporation (Barbados) Inc. | System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations |
| JP2019528320A (en) | 2016-08-31 | 2019-10-10 | レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ | Cromolyn composition for the treatment of chronic cough due to idiopathic pulmonary fibrosis |
| WO2018067341A1 (en) | 2016-10-07 | 2018-04-12 | Patara Pharma, LLC | Cromolyn compositions for treatment of pulmonary fibrosis |
| US10195147B1 (en) | 2017-09-22 | 2019-02-05 | Otitopic Inc. | Dry powder compositions with magnesium stearate |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB995256A (en) | 1961-02-20 | 1965-06-16 | Astra Apotekarnes Kem Fab | Quaternary ammonium salts having anti-arrhythmic activity |
| AU762127B2 (en) * | 1998-06-09 | 2003-06-19 | Nortran Pharmaceuticals Inc. | Compositions and methods for treatment of cough |
| US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
-
2012
- 2012-09-06 WO PCT/GB2012/052191 patent/WO2013034910A1/en active Application Filing
- 2012-09-06 WO PCT/GB2012/052190 patent/WO2013034909A1/en active Application Filing
- 2012-09-06 JP JP2014529067A patent/JP2014525471A/en active Pending
- 2012-09-06 KR KR1020147008888A patent/KR20140069091A/en not_active Application Discontinuation
- 2012-09-06 GB GBGB1304501.8A patent/GB201304501D0/en not_active Ceased
- 2012-09-06 EP EP12758876.2A patent/EP2753323A1/en not_active Withdrawn
- 2012-09-06 US US14/342,490 patent/US20140242174A1/en not_active Abandoned
- 2012-09-06 GB GBGB1304499.5A patent/GB201304499D0/en not_active Ceased
- 2012-09-06 CN CN201280054306.4A patent/CN103974699A/en active Pending
- 2012-09-06 AU AU2012306076A patent/AU2012306076A1/en not_active Abandoned
- 2012-09-06 MX MX2014002675A patent/MX2014002675A/en not_active Application Discontinuation
- 2012-09-06 GB GB201311021A patent/GB2499559B8/en not_active Expired - Fee Related
- 2012-09-06 SG SG11201400325WA patent/SG11201400325WA/en unknown
- 2012-09-06 EA EA201490538A patent/EA201490538A1/en unknown
- 2012-09-06 CA CA2847817A patent/CA2847817A1/en not_active Abandoned
-
2014
- 2014-03-04 IL IL231301A patent/IL231301A0/en unknown
- 2014-03-05 ZA ZA2014/01658A patent/ZA201401658B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103974699A (en) | 2014-08-06 |
| GB201304501D0 (en) | 2013-04-24 |
| MX2014002675A (en) | 2014-04-25 |
| AU2012306076A1 (en) | 2014-03-20 |
| GB201311021D0 (en) | 2013-08-07 |
| GB2499559A (en) | 2013-08-21 |
| ZA201401658B (en) | 2015-04-29 |
| EA201490538A1 (en) | 2014-08-29 |
| EP2753323A1 (en) | 2014-07-16 |
| GB2499559B8 (en) | 2014-04-02 |
| JP2014525471A (en) | 2014-09-29 |
| KR20140069091A (en) | 2014-06-09 |
| US20140242174A1 (en) | 2014-08-28 |
| GB2499559B (en) | 2014-03-26 |
| WO2013034910A1 (en) | 2013-03-14 |
| CA2847817A1 (en) | 2013-03-14 |
| WO2013034909A1 (en) | 2013-03-14 |
| IL231301A0 (en) | 2014-04-30 |
| GB201304499D0 (en) | 2013-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2499559B (en) | Treating cough and tussive attacks | |
| HUS2100012I1 (en) | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors | |
| HK1201368A1 (en) | Security system and method | |
| EP2790382A4 (en) | Protection method and device against attacks | |
| EP2718832A4 (en) | Group authorization method and software | |
| EP2715942A4 (en) | Spike domain circuit and modeling method | |
| EP2761294A4 (en) | Biodosimetry panels and methods | |
| HK1162614A1 (en) | Method and devices for genome sequence assembly | |
| IL214482A0 (en) | Magnetic encolsure and method | |
| GB201408236D0 (en) | Composition and method | |
| GB201122195D0 (en) | Composition and method | |
| GB201110783D0 (en) | Methods and uses | |
| SG11201402692PA (en) | Security document and method of manufacturing security document | |
| GB201116774D0 (en) | Uses and methods | |
| EP2923527A4 (en) | Methods and arrangements to decode communications | |
| EP2729893A4 (en) | Security method and apparatus | |
| GB201106433D0 (en) | Composition and method | |
| IL231798A0 (en) | Method and composition | |
| EP2684567A4 (en) | Herbal polypharmaceutical for preventing and treating atherosclerosis | |
| ZA201308683B (en) | Methods and compositions suitable for preventing and treating hyperleptinemia | |
| PL2661565T3 (en) | Mechanical protection method and device | |
| GB201108490D0 (en) | Methods and uses | |
| EP2718455A4 (en) | Organic syringomycin methods and compositions | |
| EP2806600A4 (en) | Protection method and device | |
| AU2011900740A0 (en) | Game and Method |